CN102178694B - Liquid preparation of sodium ascorbyl phosphate - Google Patents
Liquid preparation of sodium ascorbyl phosphate Download PDFInfo
- Publication number
- CN102178694B CN102178694B CN 201110115702 CN201110115702A CN102178694B CN 102178694 B CN102178694 B CN 102178694B CN 201110115702 CN201110115702 CN 201110115702 CN 201110115702 A CN201110115702 A CN 201110115702A CN 102178694 B CN102178694 B CN 102178694B
- Authority
- CN
- China
- Prior art keywords
- liquid preparation
- antiseptic
- ascorbyl phosphate
- hpo
- nah
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a liquid preparation of sodium ascorbyl phosphate. Each 1,000 milliliters of liquid preparation contains 40 to 180 grams of Na2HPO4.7H2O, 100 to 480 grams of NaH2PO4.H2O, and 0.05 to 0.3 grams of preservative. The liquid preparation of the sodium ascorbyl phosphate has a remarkable preservative effect; and the solubility, dissolution speed and stability of the sodium ascorbyl phosphate, which is the mixture of the Na2HPO4.7H2O and NaH2PO4.H2O, are high.
Description
Technical field
The invention belongs to field of pharmaceutical preparations, relate to a kind of Pharmaceutical composition, be specifically related to a kind of liquid preparation of sodium ascorbyl phosphate and preparation method thereof.
Background technology
Sodium ascorbyl phosphate is used for clearing up intestinal before patient's colon X-light and intestinal splanchnoscopy or the operation, sodium ascorbyl phosphate goes out non-absorbent zwitterion at the intestinal internal disintegration, in intestinal, form height and ooze environment, because the character of intestinal semipermeable membrane, make the interior moisture content of body enter intestinal, common a kind of mechanical stimulus, the promotion intestinal movement of producing of the moisture content that the moisture content that itself is contained and patient take.Sodium ascorbyl phosphate makes the interior moisture content increase of intestinal soften stool, and the local nerve that sodium ascorbyl phosphate can also activate the intestinal mucosa layer reflects and the wriggling of increase intestinal wall, improves intestinal power, promotes defecation.
Chinese patent CN200910060341.7 discloses a kind of preparation method of sodium ascorbyl phosphate oral solution, its step comprises material dissolution, boiling sterilization, filtration sterilization, boiling sterilization refers in the solution of material dissolution step gained, the adding mass volume ratio is 0.02%~0.03% sodium benzoate, after solution stirring is even, 98 ℃~100 ℃ insulations 1~2 hour; Described filtration sterilization steps is cooled to below 40 ℃ for the solution with the boiling sterilization gained, and the adding mass volume ratio is 0.10%~0.13% essence, with 0.22 μ m microporous filter membrane solution is filtered again, obtains sodium ascorbyl phosphate oral solution.The method adopts the mode of high temperature to sterilize, and equipment needed thereby and consume energy all very greatly in productions brings a lot of inconvenience to industrialization.
Summary of the invention
The purpose of this invention is to provide a kind of liquid preparation of sodium ascorbyl phosphate.
A kind of liquid preparation of sodium ascorbyl phosphate provided by the invention, the described liquid preparation of every 1000ml contains the Na of 40~180g
2HPO
47H
2O, the NaH of 100~480g
2PO
4H
2O, the antiseptic of 0.05~0.3g.
Described liquid preparation is preferably oral administration solution, contains the Na of 180g in every 1000ml oral administration solution
2HPO
47H
2O, the NaH of 480g
2PO
4H
2O, the antiseptic of 0.3g also comprises the correctives of 0.4~1g, described correctives is preferably Fructus Citri tangerinae essence, saccharin sodium, described antiseptic is preferably sodium benzoate.
Described liquid preparation is preferably enema, contains the Na of 40~100g in every 1000ml enema
2HPO
47H
2O, the NaH of 100~200g
2PO
4H
2O, the antiseptic of 0.1~0.3g, the EDTA-2Na of 0.1~0.5g, described antiseptic is preferably benzalkonium chloride.
This liquid preparation of sodium ascorbyl phosphate favorable anti-corrosion effect, sodium ascorbyl phosphate adopts Na
2HPO
47H
2O and NaH
2PO
4H
2The mixture of O, its dissolubility is good, and dissolution velocity is fast, good stability.
Another object of the present invention provides a kind of preparation method of liquid preparation of sodium ascorbyl phosphate, and the method comprises the following steps:
(1) dosing: first the antiseptic of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na
2HPO
47H
2O and NaH
2PO
4H
2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
This preparation method is simple, does not need special equipment, energy savings.
The specific embodiment
The present invention is further illustrated below in conjunction with specific embodiment, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following embodiment.All technology that realizes based on foregoing of the present invention all belong to scope of the present invention.Adjuvant in following examples can be replaced with pharmaceutically acceptable similar adjuvant, perhaps reduces, increases.
Embodiment 1
Prescription:
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first
2HPO
47H
2O and NaH
2PO
4H
2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 2
Prescription:
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first
2HPO
47H
2O and NaH
2PO
4H
2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 3
Prescription:
Preparation technology:
(1) dosing: with the benzalkonium chloride of recipe quantity and the purified water stirring and dissolving of EDTA-2Na usefulness full dose 70%, add again Na first
2HPO
47H
2O and NaH
2PO
4H
2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Embodiment 4
Prescription:
Preparation technology:
(1) dosing: first sodium benzoate, saccharin sodium, the Fructus Citri tangerinae essence of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na
2HPO
47H
2O and NaH
2PO
4H
2O, the glycerol stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Experimental example 1
Embodiment 1~embodiment 4 samples carry out limit test of microbe:
The limit test of microbe result
The result shows that embodiment 1~embodiment 4 sample microbial limits are up to specification, the sample favorable anti-corrosion effect.
Experimental example 2
Embodiment 1 sample carries out influence factor's test
Sample is positioned over strong illumination (4500lx ± 500), high temperature (60 ℃) condition is carried out factors influencing, detect the quality index such as its appearance character, pH value, relative density and content respectively at sampling in the 5th day, the 10th day, and compare with 0 day testing result.Also having carried out simultaneously low-temperature test (placed 2 days at 2 ℃~8 ℃ cold compartment of refrigerator first, then under 40 ℃ of conditions, accelerate to investigate 2 days, circulate three times) and freezing-thawing test (placed 2 days at-10 ℃~-20 ℃ freezer compartment of refrigerator first, then under 40 ℃ of conditions, accelerate to investigate 2 days, circulate three times), result of the test is as follows:
Influence factor's study on the stability result
By above-mentioned result of the test as can be known, this product after placing 10 days under high light, the hot conditions, each index and relatively having no significant change in 0 day.Each index that low temperature and freezing-thawing test record and 0 day are more also without significant change, without crystallization.Therefore this product is to light, heat, and low temperature etc. are all stablized, and preserves at ambient temperature to get final product.
Experimental example 3
The sodium ascorbyl phosphate dissolution velocity test of different water of crystallization
The sodium ascorbyl phosphate mixture of getting an amount of different water of crystallization (is equivalent to Na
2HPO
40.67mol and NaH
2PO
43.45mol), add water to 1000ml under the stirring condition, stir and make the principal agent dissolving, investigate the dissolution time of the sodium phosphate of different water of crystallization.The result is as follows:
The test of sodium ascorbyl phosphate dissolution velocity
By above-mentioned result of the test as can be known, the sodium ascorbyl phosphate mixture is by Na
2HPO
4.7H
2O and NaH
2PO
4.H
2When O forms, dissolve at normal temperatures very fastly, can obviously shorten the dissolution time that feeds intake in the technique, significantly improve production efficiency, prevent the dosing overlong time and be subjected to microbial contamination.
Claims (8)
1. a liquid preparation of sodium ascorbyl phosphate is characterized in that, the described liquid preparation of every 1000ml contains the Na of 40~180g
2HPO
47H
2O, the NaH of 100~480g
2PO
4H
2O, the antiseptic of 0.05~0.3g.
2. liquid preparation according to claim 1 is characterized in that, described liquid preparation is oral administration solution.
3. liquid preparation according to claim 2 is characterized in that, contains the Na of 180g in every 1000ml oral administration solution
2HPO
47H
2O, the NaH of 480g
2PO
4H
2O, the antiseptic of 0.3g also comprises the correctives of 0.4~1g.
4. liquid preparation according to claim 3 is characterized in that, described correctives is Fructus Citri tangerinae essence, and saccharin sodium, described antiseptic are sodium benzoate.
5. liquid preparation according to claim 1 is characterized in that, described liquid preparation is enema.
6. liquid preparation according to claim 5 is characterized in that, contains the Na of 40~100g in every 1000ml enema
2HPO
47H
2O, the NaH of 100~200g
2PO
4H
2O, the antiseptic of 0.1~0.3g, the EDTA-2Na of 0.1~0.5g.
7. liquid preparation according to claim 6 is characterized in that, described antiseptic is benzalkonium chloride.
8. the preparation method of the described liquid preparation of sodium ascorbyl phosphate of claim 1, the method comprises the following steps:
(1) dosing: first the antiseptic of recipe quantity is used the purified water stirring and dissolving of full dose 70%, added again Na
2HPO
47H
2O and NaH
2PO
4H
2O, stirring and dissolving is added purified water to full dose, mixes namely to get to filter front stock solution pH, relative density and content in the middle of sampling detects;
(2) filter: after the intermediate detection is qualified, with 0.45 μ m filtering with microporous membrane solution;
(3) embedding: be ready to plastic bottle, carry out fill, after fill is good, timely sealing, capping plug, and sample presentation inspection;
(4) packing: after the fill the full inspection of sample qualified after, certified products are labelled, in the carton of packing into.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110115702 CN102178694B (en) | 2011-05-06 | 2011-05-06 | Liquid preparation of sodium ascorbyl phosphate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110115702 CN102178694B (en) | 2011-05-06 | 2011-05-06 | Liquid preparation of sodium ascorbyl phosphate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102178694A CN102178694A (en) | 2011-09-14 |
CN102178694B true CN102178694B (en) | 2013-03-20 |
Family
ID=44565100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110115702 Active CN102178694B (en) | 2011-05-06 | 2011-05-06 | Liquid preparation of sodium ascorbyl phosphate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102178694B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813675A (en) * | 2012-09-07 | 2012-12-12 | 天津市嵩锐医药科技有限公司 | Compound potassium hydrogen phosphate medicine combination for injection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2196149T3 (en) * | 1996-05-08 | 2003-12-16 | Craig A Aronchick | PURGANT PREPARATIONS NON-WATERY FOR THE COLON. |
US7687075B2 (en) * | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
CN101623298B (en) * | 2009-08-13 | 2011-09-07 | 成都顺道医药开发有限公司 | Preparation method of sodium ascorbyl phosphate oral solution |
-
2011
- 2011-05-06 CN CN 201110115702 patent/CN102178694B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102178694A (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104388416A (en) | Preparation method of microporous starch embedded lactic acid bacteria | |
CN104323986A (en) | Phloroglucinol injection and preparation method thereof | |
CN105193707A (en) | Ambroxol hydrochloride oral solution and preparation method thereof | |
CN102178694B (en) | Liquid preparation of sodium ascorbyl phosphate | |
CN102240277B (en) | Pharmaceutical composition for treating periodontitis, and preparation method and application thereof | |
CN101829060A (en) | Preparation method of clindamycin phosphate powder for injection | |
CN103690580B (en) | The microemulsion extracting method of Herba Andrographis and extract thereof | |
CN105919978A (en) | Preparation method of amoxicillin microsphere slow-release capsule | |
CN103054797A (en) | Pharmaceutical composition of pantoprazole sodium and preparation method thereof | |
CN101912365A (en) | Sulbenicillin sodium powder injection and preparation process thereof | |
CN104086531B (en) | A kind of Esomeprazole sodium compound and its pharmaceutical composition | |
CN103058999A (en) | Novel pantoprazole sodium compound and pharmaceutical composition thereof | |
CN105496942A (en) | High-solubility curcumin liquid crystal preparation method | |
CN106177454A (en) | One treats colpitic gel and preparation method thereof | |
CN101849916B (en) | Cefpiramide sodium powder injection and preparation method thereof | |
CN103432067A (en) | Ketoprofen solution and preparation method thereof | |
CN105395490B (en) | A kind of freeze-dried powder of sodium pharmaceutical composition containing dextral-rabeprazole and preparation method thereof | |
CN103705929B (en) | A kind of biocompatible microemulsion and preparation method thereof | |
CN104548058A (en) | Application of ground beetle zymolyte | |
CN102150924A (en) | Alliin-containing antistaling agent and production method thereof | |
CN102697753B (en) | Roxithromycin soft capsule preparation thereof | |
CN102552180B (en) | Clindamycin phosphate composition liensinine freeze-dried powder and preparation method thereof | |
CN101879145B (en) | Anti-HIV drug zidovudine for injection and preparation process thereof | |
CN100563632C (en) | A kind of injection fleroxacin and preparation method thereof | |
CN106967129A (en) | A kind of extracting method of raffinose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |